www.leagle.com/decision/infdco20180914k00

Sep 13, 2018 ... This matter comes before the Court on Defendants Daiichi Sankyo unopposed ... H. von Eberstein, Jr. and Theresa Breland von Eberstein, Plaintiffs, v. DAIICHI SANKYO, Inc., et al., Defendants. ..... SHEILA PHILLIPS, SUZANNE THERESE PATERSON, BILLIE MARIE HUGHES, TERRY HUGHES, JUDITH ...

law.justia.com/cases/federal/district-courts/new-jersey/njdce/1:2017cv03495/348856/12

Aug 15, 2018 ... MCDANIEL v. DAIICHI SANKYO, INC. et al, No. 1:2017cv03495 - Document 12 ( D.N.J. 2018) case opinion from the District of New Jersey US ...

www.justice.gov/opa/pr/daiichi-sankyo-inc-agrees-pay-39-million-settle-kickback-allegations-under-false-claims-act

Jan 9, 2015 ... Daiichi Sankyo Inc., a global pharmaceutical company with its U.S. headquarters in New Jersey, has agreed to pay the United States and state ...

casetext.com/case/williams-v-daiichi-sankyo-inc-3

Apr 9, 2014 ... In that vein, all doubts regarding removal must be resolved in favor of ... However, Daiichi Sankyo, Inc., Daiichi Sankyo U.S. Holdings, Inc., and ...

www.dhcs.ca.gov/formsandpubs/Documents/Settlements/Daiichi_FE_SA.pdf

California ("the State") and Daiichi Sankyo, Inc. ("DSI"), hereinafter collectively ... ( ii) United States of America, et al., ex. rel Reilly v, Daiichi-Sankyo, Inc. (Civil.

www.daiichisankyo.com/media_investors/media_relations/press_releases/detail/006968/190206_877_Pexidartinib%20FDA%20NDA%20.pdf

Feb 5, 2019 ... toxicities were more frequent with pexidartinib versus placebo (AST or ALT .... Daiichi Sankyo, Inc. ... Palmerini E, Staals EL, Maki RG, et al.

www.ncbi.nlm.nih.gov/pmc/articles/PMC5130907

All-cause health care costs (2013–2014 USD) were calculated for inpatient, outpatient, ... Patients with a claim for NV had significantly more hospitalizations ( 11.5% vs 4.2%), .... Elizabeth Marrett is an employee of Daiichi Sankyo, Inc. Winghan Jacqueline ... Jarzyna D, Jungquist CR, Pasero C, et al. .... In: Hughes RG, editor.